Insights from the First Five Years of the Prospective Ocular Tumor Study.

IF 1.9 4区医学 Q2 OPHTHALMOLOGY

Seminars in Ophthalmology Pub Date : 2025-01-28 DOI:10.1080/08820538.2025.2457043

Rachel M Malsch, Rachael B Tessem, Lauren A Dalvin

{"title":"Insights from the First Five Years of the Prospective Ocular Tumor Study.","authors":"Rachel M Malsch, Rachael B Tessem, Lauren A Dalvin","doi":"10.1080/08820538.2025.2457043","DOIUrl":null,"url":null,"abstract":"Purpose: Standardized data collection is needed to improve research for rare diseases. In this manuscript, we describe our experience establishing the Prospective Ocular Tumor Study (POTS).Methods: The ongoing POTS captures all patients with an ocular tumor seen on the Ocular Oncology Service at Mayo Clinic Rochester and collects patient demographics, tumor features, treatment, and outcomes. This manuscript reports data collected from July 2019-July 2024.Results: During a 5-year time period, 1,766 patients enrolled in the database, with 975 (55%) females, 1,732 (98%) white race, and mean age 61.5 years. The most frequent tumor types were choroidal melanoma (n = 610 [34%]), choroidal nevus (n = 575 [32%]), iris nevus (n = 95 [5.3%]), iris melanoma (n = 46 [2.6%]), and vitreoretinal lymphoma (n = 46 [2.6%]).Conclusion: The POTS is a valuable source of detailed, longitudinal data on rare ocular tumors. Expanding standardized data collection across multiple centers will facilitate improved outcomes research in ocular oncology.","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-10"},"PeriodicalIF":1.9000,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08820538.2025.2457043","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: Standardized data collection is needed to improve research for rare diseases. In this manuscript, we describe our experience establishing the Prospective Ocular Tumor Study (POTS).

Methods: The ongoing POTS captures all patients with an ocular tumor seen on the Ocular Oncology Service at Mayo Clinic Rochester and collects patient demographics, tumor features, treatment, and outcomes. This manuscript reports data collected from July 2019-July 2024.

Results: During a 5-year time period, 1,766 patients enrolled in the database, with 975 (55%) females, 1,732 (98%) white race, and mean age 61.5 years. The most frequent tumor types were choroidal melanoma (n = 610 [34%]), choroidal nevus (n = 575 [32%]), iris nevus (n = 95 [5.3%]), iris melanoma (n = 46 [2.6%]), and vitreoretinal lymphoma (n = 46 [2.6%]).

Conclusion: The POTS is a valuable source of detailed, longitudinal data on rare ocular tumors. Expanding standardized data collection across multiple centers will facilitate improved outcomes research in ocular oncology.

查看原文本刊更多论文

前瞻性眼部肿瘤研究前五年的见解。

目的：需要标准化的数据收集，以提高对罕见病的研究。在这篇文章中，我们描述了我们建立前瞻性眼肿瘤研究（POTS）的经验。方法：正在进行的POTS收集了所有在罗切斯特梅奥诊所眼科肿瘤科就诊的眼部肿瘤患者，并收集了患者的人口统计资料、肿瘤特征、治疗和结果。本文报告了2019年7月至2024年7月收集的数据。结果：在5年的时间里，1766例患者入组数据库，其中975例（55%）为女性，1732例（98%）为白人，平均年龄61.5岁。最常见的肿瘤类型为脉络膜黑色素瘤（n = 610[34%]）、脉络膜痣（n = 575[32%]）、虹膜痣（n = 95[5.3%]）、虹膜黑色素瘤（n = 46[2.6%]）和玻璃体视网膜淋巴瘤（n = 46[2.6%]）。结论：POTS是一种有价值的、详细的、纵向的眼部肿瘤资料来源。扩展跨多个中心的标准化数据收集将有助于改善眼科肿瘤学的结果研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Seminars in Ophthalmology OPHTHALMOLOGY-

CiteScore

3.20

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Seminars in Ophthalmology offers current, clinically oriented reviews on the diagnosis and treatment of ophthalmic disorders. Each issue focuses on a single topic, with a primary emphasis on appropriate surgical techniques.